You are here: Industry Insights > Vaccine

News List

Merck has supplies in hand as measles cases spike to highest number in 25 years fiercepharma
May 06, 2019
The U.S. is experiencing the greatest spike in measles cases in 25 years, but Merck, the sole producer of the measles vaccine for the U.S., says it has production in hand.
One vaccine injection could carry many doses europeanpharmaceuticalreview
May 06, 2019
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered…
Experimental Ebola vaccines elicit year-long immune response europeanpharmaceuticalreview
May 06, 2019
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year…
FDA Approves Dengvaxia drugs
May 06, 2019
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions.
Big pharma can only see the benefit of R&D for wealthy markets theguardian
May 05, 2019
At the end of April, health workers in Malawi, Ghana and Kenya began rolling out the first and so far only vaccine proved to protect against malaria.
Gene-based Zika vaccine is safe and immunogenic in healthy adults europeanpharmaceuticalreview
May 05, 2019
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
Single-dose vaccine could provide faster protection against cholera europeanpharmaceuticalreview
May 05, 2019
Researchers have shown that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks of cholera…
Heroin vaccine blocks lethal overdose europeanpharmaceuticalreview
May 05, 2019
Scientists have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug…
$100 million is to be invested to increase vaccine manufacturing in US europeanpharmaceuticalreview
May 05, 2019
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
Novel colorectal cancer vaccine shows positive phase I results europeanpharmaceuticalreview
May 05, 2019
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page